Technologies
Editas Medicine Inc (NASDAQ: EDIT)’s Outlook Shocks Bears.
In today’s recent session, 1.0 million shares of the Editas Medicine Inc (NASDAQ:EDIT) have been traded, and its beta is 2.09. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.